Goldman Sachs’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,700
Closed -$909K 6131
2024
Q3
$909K Buy
+12,700
New +$897K ﹤0.01% 4702
2018
Q3
Sell
-70,000
Closed -$3.53M 5655
2018
Q2
$3.53M Buy
+70,000
New +$3.65M ﹤0.01% 3208
2016
Q2
Sell
-49,500
Closed -$1.18M 7106
2016
Q1
$1.18M Buy
+49,500
New +$1.21M ﹤0.01% 3958

Other funds holding GMED

Goldman Sachs's GMED Position: Q1 2026 in Review

Goldman Sachs increased its Globus Medical (GMED) stake by 54% in Q1 2026, buying an estimated $35.7M and bringing the position to 1,132,162 shares worth $97.5M. The position accounts for 0.01% of the portfolio, ranked #1045.

Goldman Sachs first reported a position in GMED in Q2 2013 and has held it in 52 quarters since. The position peaked at $132M in Q2 2013. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Goldman Sachs held 1,132,162 shares of Globus Medical worth $97.5M as of Q1 2026.
  • Goldman Sachs bought 397,561 Globus Medical shares in Q1 2026, an estimated $35.7M.
  • Globus Medical made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1045 holding.
  • Goldman Sachs first reported a position in Globus Medical in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Globus Medical position peaked at $132M in Q2 2013.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.